Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000830

Drug Information
NameMonobenzone
SynonymsDermochinona; 4-(Benzyl-Oxy)Phenol; C006429; AI3-14325; NCGC00016360-02; 4-(Benzyloxyl)phenol; Monobenzone; ZINC00001748; AKOS000119555; Monobenzyl ether hydroquinone; Benoquin (TN); BSPBio_000784; UNII-9L2KA76MG5; AC1Q579O; CAS-103-16-2; C14244; NCGC00016360-01; CHEMBL1388; Novo-depigman; 4-phenylmethoxyphenol; AR-1H6680; Hydroquinone monobenzyl ether; Monobenzone; PBP; Monobenzonum [INN-Latin]; Prestwick3_000912; TL806329; Phenol, p-(benzyloxy)-; MolPort-000-519-128; CHEBI:34380; EINECS 203-083-3; BPBio1_000864; Phenol, 4-(phenylmethoxy)-; 158348_ALDRICH; B1104; SBB038524; DB00600; Alba; AB00513959; WLN: QR DO1R; Prestwick0_000912; 4-06-00-05728 (Beilstein Handbook Reference); P-BENZYLOXYPHENOL; Agerite alba; AC1L1P7V; Leucodinine; Pigmex; Hydrochinon monobenzylether; Hydroquinone monobenzyl ether; Monobenzona [INN-Spanish]; Jsp000332; Hydroquinone benzyl ether; Alba-Dome; 4-(Benzyloxy)phenol; Benzyl hydroquinone; Prestwick1_000912; HSDB 4019; P-(BENZYLOXY)PHENOL; SPBio_002973; AC-2492; I01-1484; Monobenzona; 4-(Phenylmethoxy)phenol; LS-7440; D05072; Monobenzonum; HYDROQUINONE MONOBENZYL ETHER, N F; NSC 2132; Benoquin; Monobenzone (USP/INN); S1652_Selleck; HMS1570H06; AB1001901; Monobenzyl Ether of Hydroquinone; Benzoquin; Benoquin, Monobenzone; 4-benzyloxy phenol; Monobenzyl hydroquinone; Benzyl p-hydroxyphenyl ether; Carmifal; Depigman; Hydrochinon monobenzylether [Czech]; Oprea1_698781; BRN 1958305; ICN brand of monobenzone; 4-phenylmethoxy-phenol; HMS1580P12; 103-16-2; Prestwick2_000912; BIDD:ER0003; Agerite; NSC2132; 4-Benzyloxyphenol; NSC33918; Monobenzone [INN]; CID7638; AC1Q78XV; Superlite; Monobenzon; p-Hydroxyphenyl benzyl ether; Superlite (antioxidant)
Trade NameMonobenzon; Dermochinona; Leucodinine; Carmifal; Depigman; Superlite; Pigmex
IndicationVitiligo
[ICD9: 709.01   ICD10: L80]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C13H12O2/c14-12-6-8-13(9-7-12)15-10-11-4-2-1-3-5-11/h1-9,14H,1
0H2
InChIKeyVYQNWZOUAUKGHI-UHFFFAOYSA-N
Canonical SMILESC1=CC=C(C=C1)COC2=CC=C(C=C2)O    
Therapeutic ClassDermatologicals
CAS NumberCAS 103-16-2
FormulaC13H12O2
PubChem Compound IDCID 7638.
PubChem Substance IDSID 68818.
SuperDrug ATC IDD11AX13
SuperDrug CAS ID000103162;
TargetTyrosine oxidaseInhibitor[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 008173 To Reference
Ref 2Identification of an Alkylhydroquinone from Rhus succedanea as an Inhibitor of Tyrosinase and Melanogenesis. J Agric Food Chem. 2009 Mar 25;57(6):2200-5. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543